Retrophin

Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
TheStreet.com
Wed, 09/7/16 - 10:04 am
Retrophin
Martin Shkreli
sparsentan
kidney disease
focal segmental glomerulosclerosis
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Bidness, ETC
Fri, 08/19/16 - 11:50 am
Shire
Raptor Pharmaceuticals
M&A
Retrophin
Rare Diseases
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Bloomberg
Thu, 08/18/16 - 09:27 am
Raptor Pharmaceuticals
Retrophin
Martin Shkreli
Facing new conspiracy charge, Martin Shkreli pleads not guilty
Marketwatch
Mon, 06/6/16 - 11:28 pm
Martin Shkreli
Retrophin
More charges against ex-pharmaceutical executive Shkreli
Yahoo/AP
Fri, 06/3/16 - 10:13 pm
Martin Shkreli
Retrophin
Even more charges are probably coming Martin Shkreli’s way
Marketwatch
Tue, 05/3/16 - 05:18 pm
Martin Shkreli
Retrophin
How Did Martin Shkreli Ever Become A Pharmaceutical CEO?
Forbes
Wed, 03/30/16 - 11:01 am
Martin Shkreli
Pharma CEOs
Turing Pharmaceuticals
Retrophin
The company that took on Martin Shkreli's drug-price hikes has a new target
Yahoo/Business Insider
Wed, 02/10/16 - 09:54 am
Martin Shkreli
Thiola
Retrophin
drug pricing
cystinuria
Imprimis Pharmaceuticals
One Reason We Think Biotech Has Bottomed
Seeking Alpha
Sun, 11/8/15 - 11:49 am
biotech
Allergan
AstraZeneca
Bristol-Myers Squibb
Celgene
Gilead Sciences
Horizon Pharma
Insys
Pfizer
Retrophin
Valeant Pharmaceuticals
ZS Pharma
Retrophin comes after Shkreli with a $65M suit and claims of flagrant mismanagement
Fierce Biotech
Mon, 08/17/15 - 11:12 am
Retrophin
Martin Shkreli
Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday
Xconomy
Wed, 05/27/15 - 09:52 am
Retrophin
review vouchers
Sanofi
Asklepion Pharmaceuticals
FDA
Retrophin bags rare disease approval, FDA voucher in $75M deal
Fierce Biotech
Wed, 03/18/15 - 11:30 am
Retrophin
FDA
Cholbam
Shire’s Next Targets Could Be on This List: Real M&A
Bloomberg
Wed, 01/14/15 - 10:00 am
Shire
M&A
PTC Therapeutics
SynaGeva BioPharma
Retrophin
Ultragenyx
Vertex Pharmaceuticals
Biomarin
Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals
Yahoo
Mon, 01/12/15 - 09:43 am
Retrophin
cholic acid
Asklepion Pharmaceuticals
Ousted Retrophin CEO Sold Stock While Urging Investors to Buy
TheStreet.com
Tue, 11/25/14 - 01:40 pm
Retrophin
Martin Shkreli
Retrophin sells non-core assets
Seeking Alpha
Tue, 10/14/14 - 10:13 am
Retrophin
Retrophin Assailed for 'Exorbitant' Drug-Price Hike
TheStreet.com
Wed, 09/10/14 - 08:58 am
Retrophin
drug pricing
Theola
cystinuria
Did Retrophin's CEO Share More Than Good Cheer in Twitter Posts?
Bloomberg/Businessweek
Thu, 06/5/14 - 12:05 pm
Retrophin
twitter
social media
Why Retrophin Inc. Shares Blasted Off
Motley Fool
Sat, 05/31/14 - 10:11 am
Retrophin
Retrophin disappointed FDA won't grant expedited access to RE-024 for children
Yahoo/Fly on the Wall
Mon, 04/14/14 - 11:47 am
FDA
Retrophin
RE-024
PKAN

Pages